Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Breast 2

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Overweight 2Obesity 2Melanoma 2Substance Withdrawal Syndrome 1Skin Neoplasms 1Kidney Neoplasms 1Glioma 1Glioblastoma 1Chronic Pain 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Exercise 6Counseling 6Nutrition Assessment 5Methods 3Diet Therapy 3Caloric Restriction 3Tirzepatide 2Resistance Training 2Naltrexone 2Metformin 2Megestrol Acetate 2Exenatide 2Educational Status 2Early Intervention, Educational 2Diet 2Cognitive Behavioral Therapy 2Bupropion 2sultamicillin 1semaglutide 1licogliflozin 1drospirenone and ethinyl estradiol combination 1drospirenone 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Ursodeoxycholic Acid 1Trehalase 1Tobacco Use Cessation Devices 1Tablets 1Surveys and Questionnaires 1Sugars 1Sucrose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Overweight × Naltrexone × Clear all
NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
53 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Overweight

NCT03581630 2018-08-29

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Gangnam Severance Hospital

Phase NA Completed
72 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡